Merit Medical Acquires View Point Medical for $140M, Expanding Oncology Portfolio
MMSI is trading near its 52-week low of $66.34 (2.8% above the low).
Summary
Merit Medical Systems acquired View Point Medical for approximately $140 million, enhancing its therapeutic oncology product portfolio with the OneMark® Detection Imaging System and tissue markers.
Key Events · M&A and Partnerships · MMSI
-
Strategic Acquisition Announced
Merit Medical Systems acquired View Point Medical, Inc. in a merger transaction, making it a wholly-owned subsidiary.
-
Acquisition Details and Consideration
The aggregate consideration for View Point Medical, including assumed liabilities, is approximately $140 million. This includes $90 million paid in cash at closing and two deferred payments of $25 million each on the first and second anniversaries of the closing date.
-
Expanded Oncology Portfolio
The acquisition adds View Point's OneMark® Detection Imaging System and OneMark Tissue Markers, expanding Merit's therapeutic oncology products for breast and soft tissue tumor localization.
-
Projected Financial Impact
The acquisition is projected to contribute $2M-$4M in revenue in 2026 and $14M-$16M in 2027. It is expected to be dilutive to non-GAAP EPS by approximately $0.05 in 2026 and dilutive to GAAP EPS through 2027, but accretive to non-GAAP EPS in 2027 and GAAP accretive thereafter, with sales projected to grow at least 20% annually.
Analysis · MMSI · Industrial Applications And Services
Merit Medical Systems announced a significant strategic acquisition of View Point Medical for approximately $140 million. This move expands Merit's therapeutic oncology portfolio with the OneMark® Detection Imaging System and tissue markers, targeting a substantial market of 1.3 million annual procedures in the U.S. While the acquisition is projected to be dilutive to non-GAAP EPS in 2026 and GAAP EPS through 2027, it is expected to become accretive to non-GAAP EPS in 2027 and GAAP accretive thereafter, with strong projected revenue growth and high gross margins. This strategic investment, made while the stock trades near its 52-week low, signals management's commitment to long-term growth and portfolio expansion, potentially bolstering future investor confidence.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MMSI was trading at $68.23 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.1B. The 52-week trading range was $66.34 to $107.27. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.